Alysson Muotri is professor of pediatrics and of cellular and molecular medicine at the University of California, San Diego. He also co-directs the Stem Cell Program at the university’s Moores Cancer Center.
Alysson Muotri
Associate professor
University of California, San Diego
From this contributor
With tweaks, brains in a dish may yield clear clues to autism
‘Mini-brains’ created in a dish may reveal autism’s roots and point to treatments, but they do not yet mirror some critical features of a human brain.
With tweaks, brains in a dish may yield clear clues to autism
Questions for Alysson Muotri: Applying autism tools to Zika
Mini-brains grown from stem cells in culture can reveal the effects of both autism and the Zika virus on early development.
Questions for Alysson Muotri: Applying autism tools to Zika
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”